Nurix Therapeutics, Inc.
← Back to NRIX Overview

Nurix Therapeutics, Inc. (NRIX)

Profitability & Net Margin History

Current Net Margin

-1394.34%

Nurix Therapeutics, Inc. currently has a net profit margin of -1394.34%.

Financial Fundamentals

NRIXQuarterly Data • 5Y View

Historical Margin Data

DateRev ($B)NI ($B)Net MarginChange (bps)
2026-02-280.01-0.09-1394.34%81821
2025-11-300.01-0.08-576.13%51864
2025-08-310.01-0.09-1094.77%99611
2025-05-310.04-0.04-98.66%20672
2025-02-280.02-0.06-305.38%13537
2024-11-300.01-0.06-440.75%5184
2024-08-310.01-0.05-388.91%2052
2024-05-310.01-0.04-368.39%11806
2024-02-290.02-0.04-250.33%2644
2023-11-300.02-0.04-276.77%7651
2023-08-310.02-0.04-200.26%12112
2023-05-310.03-0.02-79.14%24197
2023-02-280.01-0.04-321.11%36762
2022-11-300.01-0.05-688.74%26515
2022-08-310.01-0.05-423.58%2644
2022-05-310.01-0.05-397.14%4495
2022-02-280.01-0.04-442.09%6768
2021-11-300.01-0.04-509.76%22850
2021-08-310.01-0.03-281.26%9079
2021-05-310.01-0.03-372.05%11239
2021-02-280.01-0.02-484.43%18672
2020-11-300.01-0.02-297.71%15558
2020-08-310.00-0.02-453.29%63455
2020-05-310.000.01181.25%61390
2020-02-290.00-0.01-432.65%29340
2019-11-300.00-0.01-726.05%70311
2019-08-310.01-0.00-22.94%956
2019-05-310.01-0.00-32.50%343
2019-02-280.01-0.00-29.08%

* Basis Point (bps) change measures sequential efficiency shifts. 100 bps = 1.00% Margin change.